Boston Scientific Corporation (LON:0HOY)
104.56
-0.49 (-0.47%)
At close: Feb 21, 2025
Boston Scientific Revenue
In the year 2024, Boston Scientific had annual revenue of $16.75B USD with 17.61% growth. Boston Scientific had revenue of $4.56B in the quarter ending December 31, 2024, with 22.44% growth.
Revenue
$16.75B
Revenue Growth
+17.61%
P/S Ratio
n/a
Revenue / Employee
$348.90K
Employees
48,000
Market Cap
121.98B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Boston Scientific News
- 1 day ago - Boston Scientific announces pricing of €1.5 billion of senior notes - PRNewsWire
- 4 days ago - Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference - PRNewsWire
- 4 days ago - Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX) - GuruFocus
- 10 days ago - Sell Alert: EDWARD LUDWIG Cashes Out $1.27M In Boston Scientific Stock - Benzinga
- 10 days ago - Boston Scientific Corporation (BSX) Announces Board Member Departure - GuruFocus
- 11 days ago - What's Behind The 130% Rise In BSX Stock? - Forbes
- 12 days ago - Insider Sell Alert: John Sorenson Sells Shares of Boston Scientific Corp (BSX) - GuruFocus
- 18 days ago - Boston Scientific targets 12%-14% EPS growth for 2025 with strong FARAPULSE and WATCHMAN momentum - Seeking Alpha